These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33250343)

  • 1. A polymeric paste-drug formulation for local treatment of upper tract urothelial carcinoma.
    Kesch C; Schmitt V; Bidnur S; Thi M; Beraldi E; Moskalev I; Yago V; Bowden M; Adomat H; Fazli L; Jackson JK; Gleave ME
    Urol Oncol; 2021 Mar; 39(3):194.e1-194.e7. PubMed ID: 33250343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage topical therapy for upper tract urothelial carcinoma.
    Balasubramanian A; Metcalfe MJ; Wagenheim G; Xiao L; Papadopoulos J; Navai N; Davis JW; Karam JA; Kamat AM; Wood CG; Dinney CP; Matin SF
    World J Urol; 2018 Dec; 36(12):2027-2034. PubMed ID: 29804202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma.
    Liao RS; Gupta M; Schwen ZR; Patel HD; Kates M; Johnson MH; Hahn NM; McConkey D; Bivalacqua TJ; Pierorazio PM
    J Urol; 2018 Jul; 200(1):68-73. PubMed ID: 29307680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upper urinary tract instillations in the treatment of urothelial carcinomas: a review of technical constraints and outcomes.
    Audenet F; Traxer O; Bensalah K; Rouprêt M
    World J Urol; 2013 Feb; 31(1):45-52. PubMed ID: 23007718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma.
    Hosogoe S; Hatakeyama S; Kusaka A; Hamano I; Iwamura H; Fujita N; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Ohyama C
    Eur Urol Focus; 2018 Dec; 4(6):946-953. PubMed ID: 28753881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune checkpoint inhibition in upper tract urothelial carcinoma.
    Califano G; Ouzaid I; Verze P; Hermieu JF; Mirone V; Xylinas E
    World J Urol; 2021 May; 39(5):1357-1367. PubMed ID: 33128595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine, paclitaxel, and cisplatin as combined adjuvant approach in transitional cell carcinoma of the urothelium.
    Ecke TD; Gerullis H; Bartel P; Koch S; Ruttloff J
    Minerva Urol Nefrol; 2009 Sep; 61(3):249-56. PubMed ID: 19773726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The renal safety and efficacy of combined gemcitabine plus cisplatin and gemcitabine plus carboplatin chemotherapy in Chinese patients with a solitary kidney after nephroureterectomy.
    Sun P; Xue C; Li LR; Shao C; An X; Thomas R; Yang W; Deng YF; Jiang WQ; Shi YX
    Cancer Chemother Pharmacol; 2017 Jul; 80(1):37-44. PubMed ID: 28534209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technique of mitomycin C instillation in the treatment of upper urinary tract urothelial tumors.
    Eastham JA; Huffman JL
    J Urol; 1993 Aug; 150(2 Pt 1):324-5. PubMed ID: 8326553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of intravesical gemcitabine: a preclinical study in pigs.
    Witjes JA; Vriesema JL; van der Heijden AG; Peters GJ; Schalken JA
    Eur Urol; 2003 Nov; 44(5):615-9. PubMed ID: 14572765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
    Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained-release Formulation of Mitomycin C to the Upper Urinary Tract Using a Thermosensitive Polymer: A Preclinical Study.
    Donin NM; Duarte S; Lenis AT; Caliliw R; Torres C; Smithson A; Strauss-Ayali D; Agmon-Gerstein Y; Malchi N; Said J; Raman SS; Holden S; Pantuck A; Belldegrun AS; Chamie K
    Urology; 2017 Jan; 99():270-277. PubMed ID: 27720772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-line Pembrolizumab for Metastatic Urothelial Carcinoma: Differences in Treatment Outcomes According to the Primary Site.
    Nishiyama N; Kita Y; Ito K; Kato M; Hatakeyama S; Matsushita Y; Naito S; Miyake M; Nakanishi S; Kato Y; Shibuya T; Hayashi T; Yasumoto H; Yoshida T; Uemura M; Taoka R; Nishiyama H; Kobayashi T; Kitamura H;
    Anticancer Res; 2023 Nov; 43(11):5041-5050. PubMed ID: 37909969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I pharmacokinetic study of a single intravesical instillation of gemcitabine administered immediately after transurethral resection plus multiple random biopsies in patients with superficial bladder cancer.
    Palou J; Carcas A; Segarra J; Duque B; Salvador J; Garcia-Ribas I; Villavicencio H
    J Urol; 2004 Aug; 172(2):485-8. PubMed ID: 15247710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes.
    Metcalfe M; Wagenheim G; Xiao L; Papadopoulos J; Navai N; Davis JW; Karam JA; Kamat AM; Wood CG; Dinney CP; Matin SF
    J Endourol; 2017 Sep; 31(9):946-953. PubMed ID: 28731777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.
    Rouprêt M; Babjuk M; Burger M; Capoun O; Cohen D; Compérat EM; Cowan NC; Dominguez-Escrig JL; Gontero P; Hugh Mostafid A; Palou J; Peyronnet B; Seisen T; Soukup V; Sylvester RJ; Rhijn BWGV; Zigeuner R; Shariat SF
    Eur Urol; 2021 Jan; 79(1):62-79. PubMed ID: 32593530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized phase II marker lesion study evaluating effect of scheduling on response to intravesical gemcitabine in recurrent Stage Ta urothelial cell carcinoma of the bladder.
    Gårdmark T; Carringer M; Beckman E; Malmström PU;
    Urology; 2005 Sep; 66(3):527-30. PubMed ID: 16140071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gemcitabine and carboplatin chemotherapy in advanced transitional cell carcinoma in regard to patients with impaired renal function].
    Helke C; May M; Hoschke B
    Aktuelle Urol; 2006 Sep; 37(5):363-8. PubMed ID: 17004181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer.
    Moore MJ; Tannock IF; Ernst DS; Huan S; Murray N
    J Clin Oncol; 1997 Dec; 15(12):3441-5. PubMed ID: 9396395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathological complete response to gemcitabine and cisplatin chemotherapy for advanced upper tract urothelial carcinoma: a case report].
    Matsuki M; Takahashi A; Katou S; Takayanagi A; Takagi Y; Kamata K
    Nihon Hinyokika Gakkai Zasshi; 2013 Jan; 104(1):33-7. PubMed ID: 23457933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.